Follow The Filings

GILD Gilead Sciences

Health Care, filed as GILEAD SCIENCES INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • #231
  • Master 0.18%
  • $1K

Who owns GILD

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust <0.01% Hold 10 $1K History

1 current, options excluded

Insider trades

Open-market buys and sales by GILD's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GILD insider trades
  • None no insider bought on the open market
  • $625K sold by 1 insider outside a trading plan
  • $86.1M sold by 7 insiders under 10b5-1 plans
  1. Johanna Mercier Chief Comm & Corp Aff Officer
    Planned sale
    $469K 3,000 shares at $156.22 2.6% of stake
    Traded Oct 15 Filed Oct 16
    ↗
  2. Daniel Patrick O'Day CEO
    Planned sale
    $2.2M 15,000 shares at $147.90 2.6% of stake
    Traded Oct 1 Filed Oct 2
    ↗
  3. Johanna Mercier Chief Comm & Corp Aff Officer
    Planned sale
    $433K 3,000 shares at $144.22 2.5% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  4. Andrew D Dickinson CFO
    Planned sale
    $436K 3,000 shares at $145.29 1.8% of stake
    Traded Sep 15 Filed Sep 16
    ↗
  5. Daniel Patrick O'Day CEO
    Planned sale
    $2.2M 15,000 shares at $148.64 2.5% of stake
    Traded Sep 1 Filed Sep 2
    ↗
  6. Anthony Welters Director
    Planned sale
    $2.7M 18,000 shares at $148.62 58% of stake
    Traded Aug 26 Filed Aug 27
    ↗
  7. Jeffrey Bluestone Director
    Planned sale
    $725K 5,000 shares at $145.02 33% of stake
    Traded Aug 20 Filed Aug 21
    ↗
  8. Johanna Mercier Chief Comm & Corp Aff Officer
    Planned sale
    $3.9M 28,000 shares at $137.64 19% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  9. Andrew D Dickinson CFO
    Planned sale
    $415K 3,000 shares at $138.36 1.8% of stake
    Traded Aug 17 Filed Aug 18
    ↗
  10. Daniel Patrick O'Day CEO
    Planned sale
    $2M 15,000 shares at $130.31 2.5% of stake
    Traded Aug 3 Filed Aug 4
    ↗
  11. Johanna Mercier Chief Comm & Corp Aff Officer
    Planned sale
    $390K 3,000 shares at $129.92 2.4% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  12. Andrew D Dickinson CFO
    Planned sale
    $390K 3,000 shares at $129.93 1.7% of stake
    Traded Jul 15 Filed Jul 16
    ↗
  13. Daniel Patrick O'Day CEO
    Planned sale
    $1.9M 15,000 shares at $126.29 2.4% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  14. Johanna Mercier Chief Comm & Corp Aff Officer
    Planned sale
    $372K 3,000 shares at $123.92 2.4% of stake
    Traded Jun 15 Filed Jun 16
    ↗

Also filed in the last 12 months, not counted as buying or selling: 42 option exercises, 25 share withholdings for taxes, and 15 stock grants.

Congress

8 members of Congress traded GILD in the last three years: 16 buys and 5 sales. 16 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Jared Moskowitz D-FL-23 Buy $1K–$15K May 6 filed Jun 19
  3. Jared Moskowitz D-FL-23Child Buy $1K–$15K May 6 filed Jun 19
  4. Josh Gottheimer D-NJ-5Joint Buy $1K–$15K Jan 27 filed Feb 26
  5. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025
  6. Val T. Hoyle D-OR-4Spouse Buy $1K–$15K Oct 29, 2024 filed Sep 12, 2025

SEC filings

Recent issuer filings from EDGAR, 8 shown.

Filed Form Detail Links
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q FORM 10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated about 2 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $27.12B $28.75B $29.44B
Gross profit * $20.62B $22.5B $23.21B
Gross margin * 76.0% 78.3% 78.8%
Net income $5.66B $0.48B $8.51B
Net margin * 20.9% 1.7% 28.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $16.08B $19.17B $18.34B
Total non-current assets * $46.04B $39.82B $40.68B
Total assets $62.12B $59B $59.02B
Total current liabilities $11.28B $12B $11.81B
Total equity $22.83B $19.33B $22.7B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.01B $10.83B $10.02B
Cash from investing -$2.26B -$3.45B -$4.79B
Cash from financing -$5.12B -$3.43B -$7.74B
Net change in cash $0.673B $3.91B -$2.43B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.